CNS 2020 presentation: Distinguishing pediatric movement disorders: Uncovering aromatic L-amino acid decarboxylase (AADC) deficiency
View our symposium presentation at
CNS 2020, which discusses making a differential diagnosis of AADC deficiency Understand how the symptoms of cerebral palsy, epilepsy, movement disorders and other pediatric neurotransmitter disorders may clinically resemble AADC deficiency, complicating diagnosis Real-world clinical experiences of diagnosing AADC deficiency are discussed Review the current management strategies and emerging therapies, including data for an investigational gene therapy, for the treatment of AADC deficiency
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-AADC-0648 | March 2021
Close Register here to access the content on the site GL-CORP-0207 | June 2021
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our
Privacy Statement and our Terms and Conditions do not apply.
GL-CORP-0207 | June 2021
Close COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available,